NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NA
Post# of 194
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its Chief Executive Officer John Climaco will participate in the Virtual Investor “Ask the CEO” event. The live, moderated event is intended to provide the investment community direct access to ask their questions to Climaco on Tuesday, Dec. 6, at 11:00 a.m. ET. As part of the virtual event, Climaco will provide a brief presentation, followed by an interactive question-and-answer session. Questions can be submitted live during the event or pre-submitted by sending to firstname.lastname@example.org. A live video webcast will be available on the CNS Pharmaceuticals Events page of the company’s website, with a webcast replay available two hours following the live presentation and accessible for 90 days.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer